Interferon beta-1a FDA Link

An interferon beta-1 subtype that has a methionine at position 1, a cysteine at position 17, and is glycosylated at position 80. It functions as an ANTI-VIRAL AGENT and IMMUNOMODULATOR and is used to manage the symptoms of RELAPSING-REMITTING MULTIPLE SCLEROSIS.

Also Known As:

Avonex; Avonex Pen; Interferon beta 1a; Rebif; beta 1a, Interferon; beta-1a, Interferon

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Intercellular Signaling Peptides and Proteins: 29768
    - Cytokines: 164289
      - Interferons: 39171
        Interferon Type I: 4788
        Interferon-beta: 3127
        Interferon beta-1a: 635
- Peptides: 82426
  - Intercellular Signaling Peptides and Proteins: 29768
    - Cytokines: 164289
      - Interferons: 39171
        Interferon Type I: 4788
        Interferon-beta: 3127
        Interferon beta-1a: 635
Biological Factors: 2472
- Intercellular Signaling Peptides and Proteins: 29768
  - Cytokines: 164289
    - Interferons: 39171
      - Interferon Type I: 4788
        Interferon-beta: 3127
        Interferon beta-1a: 635

P Sánchez-Caminero Selected Research

P Sánchez-Caminero Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure